Skip to main content

Table 1 Indication for new referrals and follow up appointments during Phases 1 and 2

From: Implementation of a fetal ultrasound telemedicine service: women’s views and family costs

Primary Indication

Sub-group indication

Phase 1 number of new referrals

Phase 1 number of follow-up appointments

Phase 2 number of new referral appointments

Phase 2 number of follow-up appointments

Suspected fetal anomaly

Renal, urinary & genitalia

5

2

18

9

Central nervous system

6

4

6

5

Heart arrhythmia

1

0

1

2

Musculoskeletal

0

0

7

0

Thorax and diaphragm

0

0

1

8

Abdominal wall and gastrointestinal

3

4

9

0

Tumour

0

0

1

2

Small-for-gestational age

Singleton

4

17

8

23

Multiple pregnancy

Twin-to-twin transfusion syndrome screening and management

3

1

1

5

Small-for-gestational age

0

0

3

2

Combined testing

2

0

22

0

Other e.g. single demise

0

0

1

2

Placenta

Abnormally invasive placenta screening and management

11

3

15

4

Praevia and other (e.g. antepartum haemorrhage)

1

0

10

8

Amniotic fluid

Oligo/anhydramnios

0

0

1

1

Preterm premature rupture of membranes

1

1

0

0

Fetal infection

 

0

0

6

15

Combined testing

High risk result

0

0

1

0

Alloimmunisation

 

1

8

1

13

Previous history

Structural or genetic anomaly

2

0

2

6

 

Total

40

40

114

103